ClinConnect ClinConnect Logo
Search / Trial NCT06728267

Core Stabilization Training in Child and Adolescent Underwater Rugby Athletes

Launched by OZDEN GOKCEK · Dec 6, 2024

Trial Information

Current as of August 29, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying the effects of core stabilization training on children and adolescents who play underwater rugby. Researchers want to understand how this training might improve core muscle strength, breathing ability, and overall quality of life. The study will involve kids aged 9 to 17 who are healthy and can cooperate during the assessments. They should not have any serious respiratory issues, postural problems, or other major health concerns.

Participants will be divided into two groups: one group will receive special core training for six weeks, while the other group will continue with their regular training without any extra exercises. Throughout the study, kids will have their breathing and muscle strength tested, and their quality of life will be evaluated. This is a great opportunity for young underwater rugby athletes to improve their performance and health while contributing to important research.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Doing underwater rugby.
  • No mental problems.
  • Able to cooperate.
  • Exclusion Criteria:
  • Diagnosed with respiratory system disease.
  • Kyphoscoliosis and/or advanced postural alignment problems that will affect respiratory function.
  • Any orthopedic and neurological problems.

About Ozden Gokcek

Ozden Gokcek is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative study designs and rigorous methodologies. With a focus on ethical practices and compliance, the organization specializes in the development and management of clinical trials across various therapeutic areas. Leveraging a team of experienced professionals and strategic partnerships, Ozden Gokcek aims to facilitate the efficient progression of novel therapies from concept to market, ensuring that the highest standards of scientific integrity and patient safety are upheld throughout the research process.

Locations

İzmir, Bornova, Turkey

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported